Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma.

J Immunother Cancer · 2019 · PMC6480917 · PMID 31014399

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

showed a trendp = 0.066so close (0.05 < p ≤ 0.1)

Analysis showed a trend towards an early increase in neutrophils (baseline to d43, p = 0.066) correlating with poor clinical outcome, and a late decrease in monocytes ( p = 0.014), correlating with vaccine-antigen-specific T cell response.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.